← Evidence map

TrialBMC cancer2019

AVAiLABLE NIS - AVASTIN® in lung cancer treatment in routine oncology practice in Germany.

Mark-Oliver Zahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2019
2020
2021
2022
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31077164